Correlation Between Ironbark Capital and Bio Gene

Can any of the company-specific risk be diversified away by investing in both Ironbark Capital and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ironbark Capital and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ironbark Capital and Bio Gene Technology, you can compare the effects of market volatilities on Ironbark Capital and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ironbark Capital with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ironbark Capital and Bio Gene.

Diversification Opportunities for Ironbark Capital and Bio Gene

0.29

Correlation Coefficient

Ironbark Capital  Bio Gene

Modest diversification

The 3 months correlation between Ironbark and Bio is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Ironbark Capital and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Ironbark Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ironbark Capital are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Ironbark Capital i.e., Ironbark Capital and Bio Gene go up and down completely randomly.

Pair Corralation between Ironbark Capital and Bio Gene

Assuming the 90 days trading horizon Ironbark Capital is expected to generate 0.16 times more return on investment than Bio Gene. However, Ironbark Capital is 6.39 times less risky than Bio Gene. It trades about 0.0 of its potential returns per unit of risk. Bio Gene Technology is currently generating about -0.17 per unit of risk. If you would invest  46.00  in Ironbark Capital on October 26, 2024 and sell it today you would earn a total of  0.00  from holding Ironbark Capital or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ironbark Capital  vs.  Bio Gene Technology

Ironbark Capital

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ironbark Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Ironbark Capital is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Ironbark Capital and Bio Gene

The main advantage of trading using opposite Ironbark Capital and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ironbark Capital position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.

The idea behind Ironbark Capital and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.